Educational Wellness Information Only
This platform provides peer-reviewed research summaries and educational content about peptides for wellness and optimization purposes. Nothing on this site is intended as medical advice, diagnosis, or treatment. We do not claim any peptide can diagnose, treat, cure, or prevent any disease. Always consult a licensed healthcare provider before beginning any wellness protocol.
Statements on this site have not been evaluated by the FDA. Compounded preparations are subject to applicable state and federal regulations. Availability and eligibility vary.
Anidulafungin (Eraxis) Peptide
Echinocandin lipopeptide for invasive Candida infections.
What is Anidulafungin (Eraxis)?
Anidulafungin (Eraxis) is a echinocandin · antifungal peptide studied for candidemia and other invasive candidiasis and esophageal candidiasis. Below is an educational overview of Anidulafungin (Eraxis) peptide benefits, mechanism, common research protocols, dosage references, and known side effects.
Plain-Language Label Highlights
Brand names: Eraxis
Candidemia and other invasive Candida infections; esophageal candidiasis.
An IV antifungal that breaks down the fungal cell wall — given once daily and easy on the kidneys and liver.
- •Diarrhea
- •Low potassium
- •Elevated liver enzymes
- •Nausea
- •Headache
- •Infusion-related reactions (flushing, rash, hypotension) — slow the infusion
- •Hepatic abnormalities
- •Anaphylaxis (rare)
- •Known hypersensitivity to echinocandins
Educational summary of the FDA prescribing information. Not a substitute for the full label or medical advice. Always discuss with a licensed prescriber.
Anidulafungin (Eraxis) Mechanism of Action
Semisynthetic lipopeptide that non-competitively inhibits β-(1,3)-D-glucan synthase, disrupting fungal cell wall synthesis in Candida and Aspergillus species.
Anidulafungin (Eraxis) Research Areas & Benefits
Anidulafungin (Eraxis) Dosage & Common Research Protocols
200 mg IV loading dose, then 100 mg IV daily.
Protocols summarized for educational reference from published research. Not dosing guidance.
Anidulafungin (Eraxis) Studies & Cited Research
Anidulafungin vs fluconazole in invasive candidiasis
Superior clinical response in invasive candidiasis.
Why we trust this source: Published in a peer-reviewed scientific journal with editorial and reviewer oversight.
Citations are linked to PubMed, Google Scholar, and Crossref searches so you can verify the source independently. All references are reviewed during our editorial passes (last reviewed June 1, 2026).
Anidulafungin (Eraxis) Side Effects & Safety Considerations
- •FDA-approved.
- •No dose adjustment for renal/hepatic impairment.
- •Infusion-related reactions possible.
Explore more peptides
Educational Information Only — Not Medical Advice
All content on this page is for educational and informational purposes only. It is not medical advice, diagnosis, or treatment. We make no claims that any peptide can diagnose, treat, cure, or prevent any disease. Peptides discussed are not FDA-approved for the indications listed unless explicitly stated otherwise.
Always consult a licensed healthcare provider before beginning any wellness protocol. Statements have not been evaluated by the FDA. Compounded preparations are subject to applicable state and federal regulations. Availability, eligibility, and pricing may vary.
Ask the Library
Ask anything about peptides — answers come from our curated reference library with citations.